Find a Drug
Advanced Search

Professional

Cefzil

Clinical Pharmacology
font size

Clinical Pharmacology

Standardized susceptibility test procedures require the use of laboratory control microorganisms to control the technical aspects of the laboratory procedures. Standard cefprozil powder should provide the following MIC values:


Microorganism MIC (µg/mL)
Enterococcus faecalis ATCC 29212 4-16
Escherichia coli ATCC 25922 1-4
Haemophilus influenzae ATCC 49766 1-4
Staphylococcus aureus ATCC 29213 0.25-1
Streptococcus pneumoniae ATCC 49619 0.25-1

Diffusion Techniques: Quantitative methods that require measurement of zone diameters also provide reproducible estimates of the susceptibility of bacteria to antimicrobial compounds. One such standardized procedure3 requires the use of standardized inoculum concentrations. This procedure uses paper disks impregnated with 30 µg cefprozil to test the susceptibility of microorganisms to cefprozil.

Reports from the laboratory providing results of the standard single-disk susceptibility test with a 30-µg cefprozil disk should be interpreted according to the following criteria:


Zone diameter (mm) Interpretation
≥ 18 Susceptible (S)
15-17 Intermediate (I)
≤ 14 Resistant (R)

Interpretation should be as stated above for results using dilution techniques. Interpretation involves correlation of the diameter obtained in the disk test with the MIC for cefprozil.

As with standardized dilution techniques, diffusion methods require the use of laboratory control microorganisms that are used to control the technical aspects of the laboratory procedures. For the diffusion technique, the 30-µg cefprozil disk should provide the following zone diameters in these laboratory test quality control strains.


Microorganism Zone diameter (mm)
Escherichia coli ATCC 25922 21-27
Haemophilus influenzae ATCC 49766 20-27
Staphylococcus aureus ATCC 25923 27-33
Streptococcus pneumoniae ATCC 49619 25-32

Clinical Studies

Study One

In a controlled clinical study of acute otitis media performed in the United States where significant rates of β-lactamase-producing organisms were found, cefprozil was compared to an oral antimicrobial agent that contained a specific β-lactamase inhibitor. In this study, using very strict evaluability criteria and microbiologic and clinical response criteria at the 10 to 16 days post-therapy follow-up, the following presumptive bacterial eradication/clinical cure outcomes (ie, clinical success) and safety results were obtained:

U.S. Acute Otitis Media Study Cefprozil vs β-lactamase inhibitor-containing control drug


EFFICACY:
Pathogen % of Cases with Pathogen
(n=155)
Outcome
S. pneumoniae 48.4% cefprozil success rate 5% better than control
H. influenzae 35.5% cefprozil success rate 17% less than control
M. catarrhalis 13.5% cefprozil success rate 12% less than control
S. pyogenes 2.6% cefprozil equivalent to control
Overall 100.0% cefprozil success rate 5% less than control
Safety
Brand Name: Cefzil
Generic Name: Cefprozil

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Bookmark this page:

Parenting and Pregnancy

Get tips for baby and you.

WebMD Symptom Checker - Start Here Ringworm Slideshow: Watch and Learn

Overscheduled Families Overscheduled Families
Do you run your kids from one activity to another, day after day? If so, you should take a minute to watch.See more WebMD Videos »